Lexicon Pharma in financing agreement with Invus

(Reuters) - Lexicon also said it agreed to a $60 million product
development collaboration with Symphony Capital Partners LP and
co-investors to move its first three drug candidates into
advanced clinical development.




Read more at Reuters.com Mergers News